Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ETTX

Entasis Therapeutics (ETTX) Stock Price, News & Analysis

Entasis Therapeutics logo

About Entasis Therapeutics Stock (NASDAQ:ETTX)

Advanced Chart

Key Stats

Today's Range
$2.19
$2.19
50-Day Range
$2.18
$2.20
52-Week Range
$1.40
$3.88
Volume
800 shs
Average Volume
239,104 shs
Market Capitalization
$104.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ETTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Entasis Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ETTX Stock News Headlines

I warned you about Nvidia… now look what’s happening
Nvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before the open. That’s the kind of move Tim Sykes built his XGPT system to trade. It scans AI news in real time, filters the noise, and pinpoints when to strike. He’s now showing exactly how it works — before the next headline hits.
See More Headlines

ETTX Stock Analysis - Frequently Asked Questions

Entasis Therapeutics Holdings Inc. (NASDAQ:ETTX) posted its quarterly earnings data on Thursday, November, 4th. The company reported ($0.26) earnings per share for the quarter, hitting the consensus estimate of ($0.26).

Entasis Therapeutics (ETTX) raised $75 million in an initial public offering on Wednesday, September 26th 2018. The company issued 4,400,000 shares at a price of $16.00-$18.00 per share. Credit Suisse and BMO Capital Markets served as the underwriters for the IPO and SunTrust Robinson Humphrey and Wedbush PacGrow were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Entasis Therapeutics investors own include Sorrento Therapeutics (SRNE), VYNE Therapeutics (VYNE), Viking Therapeutics (VKTX), Allena Pharmaceuticals (ALNA), CymaBay Therapeutics (CBAY), Dynavax Technologies (DVAX) and Pfizer (PFE).

Company Calendar

Last Earnings
11/04/2021
Today
7/26/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ETTX
CIK
1724344
Fax
N/A
Employees
51
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.12)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$47.14 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-145.48%
Return on Assets
-103.75%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.65
Quick Ratio
1.65

Sales & Book Value

Annual Sales
$7 million
Price / Sales
14.97
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.66 per share
Price / Book
3.32

Miscellaneous

Outstanding Shares
47,852,000
Free Float
44,742,000
Market Cap
$104.80 million
Optionable
Not Optionable
Beta
1.33
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:ETTX) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners